Brottem John L. 4

What Happened John L. Brottem, General Counsel of Outset Medical, received a grant of 59,830 restricted stock units (RSUs) on June 26, 2026. The Form 4 reports this as an award/acquisition (code A) of 59,830 units at a reported grant price of $0.00 (acquisition value $0 on the filing). RSUs are a compensation award that can convert into common shares if and when they vest.

Key Details

• Transaction date: June 26, 2026; Form 4 filed June 29, 2026 (appears timely).
• Transaction type/code: Award/Grant (A).
• Amount: 59,830 RSUs; reported price $0.00; acquisition value shown as $0.
• Shares owned after transaction: Not specified in the provided filing.
• Footnote (vesting): 33.33% of the RSUs vest on June 26, 2027; the remaining 66.67% vest in equal quarterly installments over the following two years (vesting dates: Feb 15, May 15, Aug 15, Nov 15), subject to continuous service.
• No 10b5-1 plan, tax-withholding sale, or late-filing indication noted in the supplied data.

Context RSUs are a form of equity compensation that only become actual shares if they vest according to the schedule; their eventual value depends on Outset Medical’s future stock price. Grants like this are common as part of executive compensation and do not, by themselves, indicate a buying or selling signal by the insider.